CIK 0001127537
- Non-accelerated filer
- Smaller reporting company
Pulmonx Corp
Sign in to watch- Ticker
- LUNG
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 650-364-0400
- Business address
- 700 CHESAPEAKE DRIVE, REDWOOD CITY, CA, 94063
- Former names
- PULMONX
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $177,048
- in 4 filings
Net −$177,048. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-02 | French Glendon E. III President and CEO | Sale | −2,708 | $1.43 | $4K | 1,474,616 |
| 2026-03-02 | French Glendon E. III President and CEO | Sale | −6,737 | $1.43 | $10K | 1,467,879 |
| 2026-03-02 | French Glendon E. III President and CEO | Sale | −58,368 | $1.43 | $83K | 1,409,511 |
| 2026-03-02 | Rose Geoffrey Beran CHIEF COMMERCIAL OFFICER | Sale | −835 | $1.43 | $1K | 372,631 |
| 2026-03-02 | Rose Geoffrey Beran CHIEF COMMERCIAL OFFICER | Sale | −2,125 | $1.43 | $3K | 370,506 |
| 2026-03-02 | Rose Geoffrey Beran CHIEF COMMERCIAL OFFICER | Sale | −1,861 | $1.43 | $3K | 368,645 |
| 2026-03-02 | Rose Geoffrey Beran CHIEF COMMERCIAL OFFICER | Sale | −2,911 | $1.43 | $4K | 365,734 |
| 2026-03-02 | Rose Geoffrey Beran CHIEF COMMERCIAL OFFICER | Grant or award | +100,000 | 465,734 | ||
| 2026-03-02 | Lehman David Aaron GENERAL COUNSEL | Sale | −1,163 | $1.43 | $2K | 251,829 |
| 2026-03-02 | Lehman David Aaron GENERAL COUNSEL | Sale | −4,433 | $1.43 | $6K | 247,396 |
| 2026-03-02 | Lehman David Aaron GENERAL COUNSEL | Sale | −2,590 | $1.43 | $4K | 244,806 |
| 2026-03-02 | Lehman David Aaron GENERAL COUNSEL | Sale | −4,051 | $1.43 | $6K | 240,755 |
| 2026-03-02 | Lehman David Aaron GENERAL COUNSEL | Grant or award | +150,000 | 390,755 | ||
| 2025-12-08 | Florin Daniel P Director | Sale 10b5-1 | −23,321 | $1.99 | $46K | 93,910 |
| 2025-12-01 | French Glendon E. III President and CEO | Sale | −2,524 | $1.57 | $4K | 283,605 |
| 2025-12-01 | French Glendon E. III President and CEO | Sale | −6,281 | $1.57 | $10K | 277,324 |
| 2025-12-01 | French Glendon E. III President and CEO | Grant or award | +1,200,000 | 1,477,324 | ||
| 2025-12-01 | French Glendon E. III President and CEO | Grant or award · Performance Stock Units | +800,000 | 800,000 | ||
| 2025-12-01 | Rose Geoffrey Beran CHIEF COMMERCIAL OFFICER | Sale | −683 | $1.57 | $1K | 379,105 |
| 2025-12-01 | Rose Geoffrey Beran CHIEF COMMERCIAL OFFICER | Sale | −1,738 | $1.57 | $3K | 377,367 |
Page 3 of 12 · 235 trades